Anika Therapeutics Announces Top-Line Results from CINGAL Trial in Knee OA
In the Phase III 16-02 clinical trial of Anika Therapeutics' CINGAL, statistically significant results in pain reduction were not demonstrated at the primary endpoint of 26 weeks. Jun 20, 2018